Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1761642A details an efficient asymmetric hydrogenation process for chiral beta-amino acids, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel fluoride-catalyzed synthesis of 1,4,2-dioxazole intermediates offers mild conditions and high purity for pharmaceutical manufacturing supply chains globally.
Novel high-boiling solvent method achieves >99.88% purity. Reduces energy consumption and wastewater compared to traditional water refining.
Novel 3-step modular synthesis of indomethacin analogues via Pd-catalyzed C2 functionalization. Reduces steps and enhances supply chain reliability for API manufacturing.
Patent CN101353328B details a green synthesis route for quinazoline intermediates, offering cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN108623618B reveals solid catalyst method for Cefminox Sodium ensuring high purity and reduced environmental waste for supply chain stability.
Novel quinine-catalyzed synthesis delivers high enantioselectivity and yield for pharmaceutical intermediates ensuring supply chain stability and cost efficiency.
Patent CN116354843B reveals active ester method for high-purity iopromide. Enhances supply chain stability and reduces manufacturing costs significantly.
Novel synthesis of pefloxacin derivatives for antitumor applications. Enhanced selectivity and scalable process for pharmaceutical intermediates.
Patent CN110724064A details a nickel-catalyzed route for 2-cyclohexylbenzamide, offering cost-effective pharma intermediate manufacturing with simplified supply chains.
Novel chlorination route for Amantadine synthesis offers high purity and cost efficiency. Ideal for pharmaceutical intermediate supply chains seeking scalable solutions.
Advanced asymmetric oxidation process for high-purity Esomeprazole Sodium. Reduces impurities and enhances supply chain stability for global pharmaceutical manufacturers.
Patent CN108864110A reveals a novel ethanol-based synthesis for naphthoquinone derivatives, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel pH-dependent resolution method for Isavuconazole Intermediate 4 offering high purity and reduced operational complexity for pharmaceutical supply chains globally.
Patent CN114573411B reveals a safer synthesis route for Palonosetron intermediates, eliminating n-hexane and improving purity for reliable pharmaceutical intermediates supplier partnerships.
Patent CN109593143B reveals a novel two-step crystallization process for high-purity gamma-ICD, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101250170B details a Pd-catalyzed route for dihydrofuran intermediates. Offers high stereoselectivity and simplified purification for pharmaceutical manufacturing cost reduction.
Novel catenane resolving agent method ensures high ee values and scalable production for pharmaceutical intermediates.
Advanced synthesis of 5-amino-2,4-diiodo-1,3-phthalic acid via selective deiodination. Reliable pharmaceutical intermediate supplier for contrast agent quality control.
Patent CN113322219A reveals high-efficiency biocatalytic route for curcumin glucosides offering enhanced solubility and scalable production for pharmaceutical and food industries